Idiopathic red lesion: case series

Yıl 2022, , 342 - 346, 27.09.2022

Kübra Ceran Deveci , Yasin Çiçek , Abdulsamet Tanık

https://doi.org/10.21673/anadoluklin.1053380

Öz

The first step in the treatment of periodontal diseases is to mechanically remove plaque and dental calculus, which play a role in the etiology of periodontal diseases, and to establish oral hygiene. In some cases of oral diseases, some drugs and chemical agents can be used for various reasons in addition to mechanical treatment. Corticosteroids are frequently used in oral mucocutaneous diseases because of their strong anti-inflammatory, antiallergic and immunosuppressive effects in the treatment of many other diseases. Although there are different ways of using corticosteroids, the topical form is often preferred in the treatment of oral lesions associated with oral mucosal diseases. This case series aims to evaluate the effect of topical corticosteroid application on red lesions in the gingiva that do not heal with conventional periodontal treatment.

Anahtar Kelimeler

gingivitis, idiopathic, corticosteroid

İdiopatik kırmızı lezyon: olgu serisi

Öz

Periodontal hastalıkların tedavisinde ilk basamak, periodontal hastalıkların etiyolojisinde rol oynayan bakteri plağı ve diştaşlarının mekanik olarak uzaklaştırılması ve oral hijyenin sağlanmasıdır. Bazı oral hastalık durumlarında mekanik tedaviye ek olarak, çeşitli sebeplerle bazı ilaç ve kimyasal ajanlar kullanılabilmektedir. Kortikostreoidler; birçok hastalığın tedavisinde güçlü antiinflamatuar, antialerjik ve immünosupresif etkileri nedeniyle oral mukokütonoz hastalıklarda sıklıkla kullanılmaktadır. Kortikosteroidlerin farklı kullanım şekilleri olsa da oral mukozal hastalıklarla ilişkili ağız lezyonlarının tedavisinde sıklıkla topikal formu tercih edilmektedir. Bu olgu serisinin amacı, konvansiyonel periodontal tedaviyi takiben iyileşmeyen dişetindeki kırmızı lezyonlara topikal kortikosteroid uygulamasının etkisini değerlendirmektir.

Anahtar Kelimeler

gingivitis, idiyopatik, kortikosteroid

Kaynakça

• Karapınar G. Ünür M. Drugs used in the treatment of oral mucosal diseases Yeditepe Dent J . 2019;15(3):336-73.
• Tekin M, Çam OH. Oral mukoza hastalıkları ve semptomatolojisi. Klinik Gelişim Dergisi. 2012;25:93-8.
• Cicek Y, Ertaş U. The normal and pathological pigmentation of oral mucous membrane: a review. J Contemp Dent Pract.2003:4(3):76-86.
• Epstein JB, Gordon S. Managing patients with red or red-white oral lesions. J Can Dent Assoc. 2013;79:d95.
• Vijayavel T, Praveena NM, Ramani P.Corticosteroids in oral diseases. Indian Journal of Drugs and Diseases. 2012;1:168-70.
• Thongprasom K, Dhanuthai K. Steriods in the treatment of lichen planus: a review. J Oral Sci. 2008;50(4):377-85.
• Ramadas AA, Jose R, Arathy SL, Kurup S, Chandy ML, Kumar SP. Systemic absorption of 0.1% triamcinolone acetonide as topical application in management of oral lichen planus. Indian J Dent Res. 2016;27(3):230-5.
• Kinane DF, Peterson M, Stathopoulou PG. Environmental and other modifying factors of the periodontal diseases. Periodontol 2000. 2006;40(1):107-19.
• Drisko CH. Nonsurgial periodontal therapy. Periodontol 2000. 2001;25(1):77-88.
• Carbone M, Goss E, Carrozzo M, et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med. 2003;32(6):323-9.
• Thongprasom K, Chaimusig M, Korkij W, Sererat T, Luangjarmekorn L, Rojwattanasirivej S. A randomized-controlled trial to compare topical cyclosporin with triamcinolone acetonide for the treatment of oral lichen planus. J Oral Pathol Med. 2007;36(3):142-6.
• Voute AB, Schulten EA, Langendijk PN, Kostense PJ, van der Waal I. Fluocinonide in an adhesive base for treatment of oral lichen planus: a double-blind, placebo-controlled clinical study. Oral Surg Oral Med Oral Pathol. 1993;75(2):181-5.
• Siegel MA. Strategies for management of commonly encountered oral mucosal disorders. J Calif Dent Assoc. 1999;27(3):210–2.
• Thompson AC, Nolan A, Lamey J. Minor aphthous oral ulceration: a double-blind cross-over study of beclomethasone dipropionate aerosol spray. Scott Med J. 1989; 34(5):531-2.
• Wongtim, K. Subbalekha K, Chaisuparat R, Thongprasom K. Plasma cell mucositis: an unusual case. American Journal of Oral Medicine. 2018:4(2):18-23.